02660nam a2200301 4500001000800000005001700008007000300025008004100028040000800069041000800077100003400085245007900119300002500198520167400223650003301897650003201930650003201962650004301994700002602037700002602063700002802089700002202117700003002139700003102169773011002200942003102310999001702341ESSALUD20260903101808.0ta t pe ||||| |||| 00| 0 spa d aBMG aeng aPerera, Divaka eAutor954527 aLeft ventricular unloading in high-risk percutaneous coronary intervention apáginas: 1779-1789 aBackground: Complex percutaneous coronary intervention (PCI) in patients with severely impaired left ventricular function carries a high risk of death and complications. Whether percutaneous left ventricular unloading improves outcomes remains unclear. Methods: We randomly assigned 300 patients with severe left ventricular dysfunction and extensive coronary artery disease in a 1:1 ratio to a strategy of elective unloading with a microaxial flow pump or to standard care during planned complex PCI. The primary outcome was a hierarchical composite that included death from any cause, disabling stroke, spontaneous myocardial infarction, hospitalization for cardiovascular causes, or periprocedural myocardial injury at a minimum of 12 months, as analyzed according to a win ratio. Results: A total of 148 patients were assigned to receive a microaxial flow pump and 152 to receive standard care. At a median of 22 months (interquartile range, 16 to 30), 36.6% of pairwise comparisons favored the microaxial flow pump, and 43.0% favored standard care (win ratio, 0.85; 95% confidence interval [CI], 0.63 to 1.15; difference, −6.4 percentage points; P=0.30). Death from any cause occurred in 47 patients in the microaxial-flow-pump group and 33 in the standard-care group (hazard ratio, 1.54; 95% CI, 0.99 to 2.41). There was no material between-group difference in the risk of bleeding or vascular complications. Conclusions: Among patients with severely impaired left ventricular function undergoing complex PCI, elective left ventricular unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes at a minimum of 12 months.  aCARDIOLOGÍA GENERAL953638 aENFERMEDAD CORONARIA914895 aINFARTO DE MIOCARDIO913202 aSOPORTE CIRCULATORIO MECÁNICO954520 aRyan, Matthew 954528 aEzad, Saad M. 954529 aKhan, Sohail Q. 954530 aWebb, Ian 954531 aO’Kane, Peter D.954532 aWeerackody, Roshan 9545330 022717922676dMassachusetts NEJM GroupoNEJM015tThe New England Journal of Medicine wESSALUDx0028-4793 cARTICULOSe2026-08-31zsqb c22920d22920